XPC and malignant colon neoplasm: One study investigating a possible relationship between DNA damage repair and drug response revealed that siRNA mediated downregulation of the damage recognition NER protein XPC increased cisplatin sensitivity in colon cancer cells, while overexpression of XPC led to an increase in resistance [37].